https://www.cnbc.com/2025/08/07/eli-lilly-lly-q2-2025-earnings-report.html
0
0
39 words
0
Comments
Eli Lilly hiked its 2025 guidance and posted second-quarter earnings that topped estimates on strong demand for its blockbuster weight loss and diabetes drugs.
You are the first to view
Create an account or login to join the discussion